Avidity Biosciences Inc. (RNA)
29.86
-0.78 (-2.55%)
At close: Mar 03, 2025, 12:08 PM
Avidity Biosciences Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 10.9M | 9.56M | 9.22M | 9.33M | 6.79M | 2.32M | 379K |
| Cost of Revenue | n/a | 2.1M | 1.39M | 639K | 37.6M | 14.54M | 8.44M |
| Gross Profit | 10.9M | 7.46M | 7.84M | 8.69M | -30.82M | -12.22M | -8.06M |
| Operating Income | -378.94M | -235.6M | -178.91M | -118.05M | -44.28M | -17.33M | -10.5M |
| Interest Income | 56.88M | 23.97M | 4.97M | 104K | 206K | 7.39M | n/a |
| Pretax Income | -322.3M | -212.22M | -174M | -118.01M | -44.35M | -24.73M | -11.22M |
| Net Income | -322.3M | -212.22M | -169.08M | -117.37M | -43.98M | -32.12M | -11.93M |
| Selling & General & Admin | 86.24M | 54.19M | 37.73M | 26.2M | 13.46M | 5.11M | 2.44M |
| Research & Development | 303.59M | 190.97M | 150.4M | 101.18M | 37.6M | 14.54M | 8.44M |
| Other Expenses | n/a | n/a | 4.92M | 42K | -78K | n/a | n/a |
| Operating Expenses | 389.83M | 245.16M | 188.14M | 127.38M | 51.06M | 19.65M | 10.88M |
| Interest Expense | n/a | n/a | n/a | n/a | 209K | 7.39M | 718K |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 389.83M | 245.16M | 188.14M | 127.38M | 51.06M | 19.65M | 10.88M |
| Income Tax | n/a | n/a | -4.92M | -639K | -373K | 7.39M | 718K |
| Shares Outstanding (Basic) | 111.58M | 73.01M | 52.16M | 41.43M | 21.66M | 37.51M | 20.68M |
| Shares Outstanding (Diluted) | 111.58M | 73.01M | 52.16M | 41.43M | 21.66M | 37.51M | 20.68M |
| EPS (Basic) | -2.89 | -2.91 | -3.24 | -2.83 | -2.03 | -0.86 | -0.58 |
| EPS (Diluted) | -2.89 | -2.91 | -3.24 | -2.83 | -2.03 | -0.86 | -0.58 |
| EBITDA | -378.94M | -233.5M | -177.53M | -117.41M | -43.77M | -16.75M | -10.12M |
| Depreciation & Amortization | n/a | 2.1M | 1.39M | 639K | 373K | 597K | 383K |